Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP)

Europace

Volumn 15, Issue 1, 2013, Pages 135-140

  Friberg, Leif ^a   Engdahl, Johan ^b   Frykman, Viveka ^a   Svennberg, Emma ^a   Levin, Lars Åke ^c   Rosenqvist, Mårten ^d  

^a DANDERYD HOSPITAL   (Sweden)

^b Halland Hospital   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Anticoagulation; Atrial fibrillation; Bleeding; Epidemiology; Screening; Silent atrial fibrillation; Stroke

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; AGE; ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEALTH PROGRAM; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PRIORITY JOURNAL;

AGED; ATRIAL FIBRILLATION; COMORBIDITY; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; REGISTRIES; RISK FACTORS; STROKE; SWEDEN;

EID: 84871221710     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus217     Document Type: Article

References (40)

1. Flegel KM, Shipley MJ, Rose G. Risk of stroke in non-rheumatic atrial fibrillation. Lancet 1987;1:526-9 (Pubitemid 17020736)
2. Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study. Neurology 1978;28:973-7 (Pubitemid 8401525)
3. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998;98:946-52 (Pubitemid 28446646)
4. Friberg L, Hammar N, Pettersson H, Rosenqvist M. Increased mortality in paroxysmal atrial fibrillation: Report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF). Eur Heart J 2007;28:2346-53 (Pubitemid 47537782)
5. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke 1997;28:316-21 (Pubitemid 27096997)
6. Kwok CS, Loke YK, Hale R, Potter JF, Myint PK. Atrial fibrillation and incidence of dementia: A systematic review and meta-analysis. Neurology 2011;76:914-22
7. Thrall G, Lip GY, Carroll D, Lane D. Depression, anxiety, and quality of life in patients with atrial fibrillation. Chest 2007;132:1259-64 (Pubitemid 47621002)
8. Paquette M, Roy D, Talajic M, Newman D, Couturier A, Yang C et al. Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation. Am J Cardiol 2000;86:764-8
9. Ericson L, Bergfeldt L, Bjorholt I. Atrial fibrillation: The cost of illness in Sweden. Eur J Health Econ 2011;12:479-87
10. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146:857-67 (Pubitemid 351650486)
11. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361: 1139-51
12. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:883-91
13. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365:981-92
14. Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: Prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Can J Cardiol 2011;27:74-90
15. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31: 2369-429
16. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. ACC/ AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: Full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines. Europace 2006;8:651-745 (Pubitemid 44472247)
17. Friberg L, Hammar N, Ringh M, Pettersson H, Rosenqvist M. Stroke prophylaxis in atrial fibrillation: Who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study). Eur Heart J 2006;27:1954-64 (Pubitemid 44297370)
18. Dagres N, Nieuwlaat R, Vardas PE, Andresen D, Le'vy S, Cobbe S et al. Genderrelated differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: A report from the Euro Heart Survey on atrial fibrillation. Am Coll Cardiol 2007;49:572-7 (Pubitemid 46177436)
19. Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: Report from the Stockholm Cohort of Atrial Fibrillation. Eur Heart J 2009;31: 967-75
20. Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL. Stroke with intermittent atrial fibrillation: Incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 2000;35:183-7 (Pubitemid 30061278)
21. Savelieva I, Camm AJ. Clinical relevance of silent atrial fibrillation: Prevalence, prognosis, quality of life, and management. J Interv Card Electrophysiol 2000;4: 369-82
22. Rizos T, Wagner A, Jenetzky E, Ringleb PA, Becker R, Hacke W et al. Paroxysmal atrial fibrillation is more prevalent than persistent atrial fibrillation in acute stroke and transient ischemic attack patients. Cerebrovasc Dis 2011;32:276-82
23. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012;366:120-9
24. Glotzer TV. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation 2003;107:1614-9 (Pubitemid 36397330)
25. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-70 (Pubitemid 32537350)
26. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation. Chest 2010;137:263-72
27. Wilson JMG, Jungner G. Principles and Practice of Screening for Disease. Geneva: world Health Organization (WHO); 1968
28. Friberg L, Rosenqvist M, Lip GY. Net clinical benefit of warfarin in patients with atrial fibrillation: A Report from the Swedish Atrial Fibrillation Cohort Study. Circulation 2012;125:2298-307
29. Doliwa PS, Frykman V, Rosenqvist M. Short-term ECG for out of hospital detection of silent atrial fibrillation episodes. Scand Cardiovasc J 2009;43:163-8
30. Doliwa PS, Rosenqvist M, Frykman V. Paroxysmal atrial fibrillation with silent episodes: Intermittent versus continuous monitoring. Scand Cardiovasc J 2012;46: 144-8
31. Doliwa Sobocinski P, Anggardh Rooth E, Frykman Kull V, von Arbin M, Wallen H, Rosenqvist M. Improved screening for silent atrial fibrillation after ischaemic stroke. Europace 2012;14:1112-6
32. Gold M, Hohnloser S, Connolly S, Israel C, Morillo C, Chu-Pak L et al. Relationship between duration of pacemaker-detected atrial tachyarrhthmias and stroke or embolus: Insights from the ASSERT trial (Abstract). Heart Rhytm 2012;9:s24
33. Brenner SR. Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. Heart Rhythm 2010;7:e1; author reply e-2
34. Dublin S, Anderson ML, Haneuse SJ, Heckbert SR, Crane PK, Breitner JC et al. Atrial fibrillation and risk of dementia: A prospective cohort study. J Am Geriatr Soc 2011;59:1369-75
35. Barber M, Tait RC, Scott J, Rumley A, Lowe GD, Stott DJ. Dementia in subjects with atrial fibrillation: Hemostatic function and the role of anticoagulation. J Thromb Haemost 2004;2:1873-8 (Pubitemid 40192736)
36. Pengo V. Long-term warfarin use to prevent both stroke and dementia in subjects with atrial fibrillatioñ J Thromb Haemost 2004;2:1871-2 (Pubitemid 40192735)
37. Ghatnekar O, Persson U, Glader EL, Terent A. Cost of stroke in Sweden: An incidence estimate. Int J Technol Assess Health Care 2004;20:375-80 (Pubitemid 39079575)
38. Davidson T, Husberg M, Janzon M, Levin L. The cost of thromboembolic events and their prevention among patients with atrial fibrillation. J Atrial Fibrillation 2012; 2:1-11
39. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011;11:450
40. Smith JG, Platonov PG, Hedblad B, Engstrom G, Melander O. Atrial fibrillation in the Malmo Diet and Cancer study: A study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol 2010;25:95-102